Bullish Trends in Biotech Today-Rebalance Portfolio with Healthcare…Update-1 Biogen
Update-1 10/22. Some follow through in biotech rally but sold off mirroring the NASDAQ about 2p,Maybe BREXIT related but we'll see later this week after many earnings reports. Large caps have been leading and although the IBB was up 1.66% it sold off from $107 level $106. Biogen (BIIB) helped...
Surprisingly Strong Earnings Spark Healthcare Stocks : Time to Rebalance Your Portfolio…Update-1
Update-1 Large caps were mixed but our top picks are doing well: ABBV,BMY,MRK,RHHBY. But bad news from JNJ and BA may have curbed buyer's sentiment. United Health (UNH) off Mondays lows of $220 to $245. In summary it looks like a good time fo adding larger cap healthcare weighting. Roche...
Biotech Stocks Mired in Uncertainty: China Deal, Drug Pricing Politics and Earnings Outlook…Update-2 Rally Day
Update-2 10/13...Biotech IPOs Remain Weak-Recent rally was weak for small cap biotechs Vir Biotechnology (VIR): A clinical stage immunology and infectious disease Company focused on new therapies for hepatitis (HBV), Influenza A, HIV and TB went public on Friday. Despite aa broad experienced...
Large Cap Biopharma in Focus: Core Positions…Risk OFF…Updates
10/09/19 Better tape today but a lot of random churning and tactical trading, biopharma under siege? NASDAQ up 1.17%. Talk about mini-deal with China. Large cap leaders with IBB flat: REGN MRK BMY. Mid caps weak with XBI down 0.63%. JNJ woes continue with $8B verdict on Risperdal, stock down 2%...
Biotech Snapshot: Bears Are Digging In…Update-2… Upside Reversal
Update-2 10/4 Broad Rally day: all major averages up 1.4%, NAZ at 7982. Risk back on. But biotech lags major indices IBB up 0.75%, XBI up 0.21% to $76.82. Better trade for biotech has been large caps: ABBV, AMGN, MRK,RHHBY VRTX. Mid-cap movers: BLUE up 3.97%, GWPH up 5.22%, NKTR up 4.2%, SRPT...